Table 2 Acutely ill COVID-19 inpatient demographics and clinical data
Variable | Ward Inpatients (n = 22) | ICU Inpatients (n = 22) |
|---|---|---|
Age (yrs), median (IQR) | 60.0 (21.5) | 58.0 (17.5) |
Male sex, no. (%) | 12 (54.5) | 12 (54.5) |
Weight (kg), median (IQR) | 84.8 (14.8) | 90.0 (28.3) |
Height (cm), median (IQR) | 169.0 (9.2) | 170.0 (9.0) |
BMI, median (IQR) | 28.6 (5.6) | 30.5 (7.6) |
MODS, median (IQR) | – | 5.0 (1.0) |
SOFA Score, median (IQR) | – | 5.5 (5.8) |
Comorbidities, no. (%) | ||
Diabetes | 4 (18.2) | 10 (45.5) |
Hypertension | 9 (40.9) | 9 (40.9) |
Coronary artery/heart disease | 1 (4.5) | 2 (9.1) |
Chronic/congestive heart failure | 0 (0.0) | 0 (0.0) |
Chronic kidney disease | 1 (4.5) | 2 (9.1) |
Cancer | 3 (13.6) | 2 (9.1) |
COPD | 0 (0.0) | 1 (4.5) |
Presenting symptoms, no. (%) | ||
Fever | 18 (81.8) | – |
Cough | 18 (81.8) | – |
Anosmia/Ageusia | 4 (18.2) | – |
Pharyngitis | 4 (18.2) | – |
Headache | 3 (13.6) | – |
Myalgias | 14 (63.6) | – |
Dyspnea | 20 (90.9) | – |
Chest pain | 3 (13.6) | – |
Nausea/Vomiting/Diarrhea | 9 (40.9) | – |
Pulmonary pathology, no. (%) | ||
Unilateral pneumonia | – | 1 (4.5) |
Bilateral pneumonia | 21 (95.5) | 20 (90.9) |
Interstitial infiltrates/R effusion | – | 1 (4.5) |
Laboratories, median (IQR) | ||
Hemoglobin | 129.5 (23.0) | 118.5 (29.8) |
White Blood Cell count | 6.8 (4.9) | 8.8 (7.9) |
Neutrophils | 5.8 (3.9) | 7.5 (7.4) |
Lymphocytes | 0.8 (0.7) | 0.7 (0.6) |
Platelets | 210.0 (68.5) | 220.0 (143.5) |
Creatinine | 69.5 (25.5) | 79.5 (86.2) |
International Normalized Ratio | 1.0 (0.1) | 1.2 (0.1) |
Lactate | 1.7 (0.9) | 1.2 (0.8) |
Partial thromboplastin time (PTT) | – | 26.5 (5.0) |
PaO2/FiO2 Ratio | – | 128.5 (62.5) |
Interventions, no. (%) | ||
Renal replacement therapy | 0 (0.0) | 5 (22.7) |
High-flow nasal cannula | 13 (59.1) | 15 (68.2) |
Non-invasive mechanical ventilation | 1 (4.5) | 6 (27.3) |
Invasive mechanical ventilation | 2 (9.1) | 20 (90.9) |
Extracorporeal membrane oxygenation | 0 (0.0) | 1 (4.5) |
Tocilizumab | 2 (9.1) | 0 (0.0) |
Steroids | 21 (95.5) | 14 (63.6) |
Vasoactive medications | 2 (10.0) | 18 (81.8) |
Antibiotics | 22 (100.0) | 22 (100.0) |
Anti-virals | 4 (18.2) | 3 (13.6) |
Antiplatelet | 4 (18.2) | 17 (77.3) |
Anticoagulation | 22 (100.0) | 21 (95.5) |
Outcomes | ||
Days, median (IQR) | 9.0 (6.8) | 15.5 (15.0) |
Died, no. (%) | 2 (9.1) | 10 (45.5) |